[IMRX] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[IMRX] Immuneering Corporation
Announcement Date
10-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -8.45%
YoY- -46.48%
Quarter Report
IMRX's Result
IMRX's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 94,419 0 0 38 94 184 190 6245.64%
PBT -12,189 -13,604 -13,246 -12,844 -11,527 -12,897 -11,092 6.50%
Tax -1,139 -1,075,403 -740 -344 -52 -29 -307 140.23%
NP -12,189 1,061,799 -12,506 -12,501 -11,527 -12,867 -10,784 8.53%
Tax Rate - - - - - - - -
Total Cost 106,608 -1,061,799 12,506 12,539 11,622 13,051 10,974 357.18%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -12.91 0.00 -2,742,434.65 -32,570.38 -12,208.67 -7,004.48 -5,688.22 -98.29%
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.43 40.16 -0.47 -0.47 -0.44 -0.49 -0.42 1.58%
EPS Diluted -0.43 40.16 -0.47 -0.47 -0.44 -0.49 -0.42 1.58%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.